Skip to Main Content

Biosimilars and key generic medicines – March 2026 update

Event 18 March 2026Location Online, via Webex, 13.00-14.00pm

An update about biosimilar and key generic medicines to support system planning and mobilisation.

Date

18 March 2026

Location

Online, via Webex, 13.00-14.00pm

About the event

Speakers from NHS England and NHS SPS provided insights to support planning and implementation of biosimilar and key generic medicines. Novel ideas about communicating and engaging patients was covered and there was an opportunity to ask questions.

This webinar was intended for NHS procurement and clinical teams implementing biosimilar and high value generic medicines. The first half of the session and the Q&A section was not recorded as some information is commercially confidential and subject to change.

Why it’s important

Implementation of biosimilar and key generic medicines requires collaborative working across the system. The use of biological medicines, including biosimilars, is expanding in clinical practice.  

Timely implementation and use of biosimilar and key generic medicines offers the NHS opportunities to deliver better value for certain conditions.

What was covered

  • An update on progress with biosimilar implementation
  • A forward view to new medicines on tariff from April 2026, and a five year strategic outlook
  • Novel ideas for communicating and engaging with patients about biosimilar implementation
  • A question and answer session with NHSE and NHS SPS colleagues

Speakers

A range of speakers from SPS and other organisations ran this event.

Non-SPS speakers

Tara Callagy

Lead Medicines Value Pharmacist, Liverpool University Hospitals NHS Foundation Trust

Barbara Sly

New to Market Biosimilars and Generics Category Lead, Medicines Procurement and Supply Chain, NHS Medicines Value & Access, NHS England

SPS speakers

Learn more about our SPS team below

Resources

The presentations by Barbara Sly and Danny Palmer and the Q&A were not recorded as some information was commercially confidential and subject to change. Information presented by Tara Callagy and Victoria Keers was correct at the time of recording. Correct guidance should be followed.

Webinar recording

Presentation resources

Slides from the presentation by Tara Callagy and Victoria Keers are available below.

Contact us

Please contact the admin team if you have any questions.

Update history

  1. Recording and slides added
  1. Changed to past event
  1. Published